The PD + Cyproheptadine group significantly prevented the downregulation of TH and decreased dopaminergic neuron loss compared to the PD group (Figure 7C, 93.69–104.97 vs. 42.41–62.93, P = 0.0028). Here, TH is linked to Parkinson disease.